 North America is expected to show the highest revenue growth and to hold the largest market shares in the global treatment-resistance depression treatment market due to advanced healthcare infrastructure and healthcare spending. NEWARK, Del, Dec. 16, 2022 GLOBE NEWSWIRE The global Treatment-Resistant Depression Therapeutics Market is experiencing rapid growth as the prevalence of depression and ... The post Treatment-Resistant Depression Therapeutics Market Value to reach US 4 Billion by 20... 